胰岛素样生长因子2 mRNA结合蛋白2:2型糖尿病与癌症的潜在桥梁
本综述总结了IGF2BP2在2型糖尿病(T2DM)和癌症中的作用。T2DM增加某些恶性肿瘤风险,可能与胰岛素抵抗、高胰岛素血症、高血糖、慢性炎症及脂肪因子和性激素失调有关。IGF2BP2通过调控糖代谢、胰岛素敏感性和肿瘤发生介导两种疾病的发病机制。
要点
- IGF2BP2参与T2DM和癌症的发病,其单核苷酸变异与两种疾病相关。
- 小鼠敲除IGF2BP2基因改善糖耐量和胰岛素敏感性。
- 转基因p62(IGF2BP2剪接变体)小鼠易患饮食诱导的脂肪肝和肝细胞癌。
核心结论
- IGF2BP2通过调控葡萄糖代谢、胰岛素敏感性和肿瘤发生介导T2DM和癌症的发病机制。
研究设计与样本
- PubMed文献综述,检索词为IGF2BP2、IMP2或p62联合癌症或T2DM,并手动检索参考文献列表。
主要发现
- T2DM患者多种恶性肿瘤风险及癌症相关死亡率增加,认为由胰岛素抵抗、高胰岛素血症、高血糖、慢性炎症及脂肪因子和性激素失调驱动。
- IGF-2具有致癌性,其功能丧失性剪接变体对T2DM有保护作用。
- IGF2BP2的单核苷酸变异(原称单核苷酸多态性)与T2DM和癌症均相关。
- 小鼠敲除IGF2BP2基因改善糖耐量和胰岛素敏感性。
- 转基因p62(IGF2BP2剪接变体)小鼠易患饮食诱导的脂肪肝病和肝细胞癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Type 2 diabetes mellitus (T2DM) and cancer share a variety of risk factors and pathophysiological features. It is becoming increasingly accepted that the 2 diseases are related, and that T2DM increases the risk of certain malignancies. OBJECTIVE: This review summarizes recent advancements in the elucidation of functions of insulin-like growth factor 2 (IGF-2) messenger RNA (mRNA)-binding protein 2 (IGF2BP2) in T2DM and cancer. METHODS: A PubMed review of the literature was conducted, and search terms included IGF2BP2, IMP2, or p62 in combination with cancer or T2DM. Additional sources were identified through manual searches of reference lists. The increased risk of multiple malignancies and cancer-associated mortality in patients with T2DM is believed to be driven by insulin resistance, hyperinsulinemia, hyperglycemia, chronic inflammation, and dysregulation of adipokines and sex hormones. Furthermore, IGF-2 is oncogenic, and its loss-of-function splice variant is protective against T2DM, which highlights the pivotal role of this growth factor in the pathogenesis of these 2 diseases. IGF-2 mRNA-binding proteins, particularly IGF2BP2, are also involved in T2DM and cancer, and single-nucleotide variations (formerly single-nucleotide polymorphisms) of IGF2BP2 are associated with both diseases. Deletion of the IGF2BP2 gene in mice improves their glucose tolerance and insulin sensitivity, and mice with transgenic p62, a splice variant of IGF2BP2, are prone to diet-induced fatty liver disease and hepatocellular carcinoma, suggesting the biological significance of IGF2BP2 in T2DM and cancer. CONCLUSION: Accumulating evidence has revealed that IGF2BP2 mediates the pathogenesis of T2DM and cancer by regulating glucose metabolism, insulin sensitivity, and tumorigenesis. This review provides insight into the potential involvement of this RNA binding protein in the link between T2DM and cancer.
引用
- Cao J, Yan W, Ma X, et al. Insulin-like Growth Factor 2 mRNA-Binding Protein 2-a Potential Link Between Type 2 Diabetes Mellitus and Cancer. J Clin Endocrinol Metab. 2021. PMID: 34061963. doi:10.1210/clinem/dgab391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。